The drug didn't hurt patients, did it?
This kind of failure seems relatively benign.
This kind of failure seems relatively benign.
According to the article, the evidence for this drug was never substantial. We know it doesn't work now, onto the next.
I guess there’s the fact it made it to Phase III before they canned it meaning more people were hopeful than if action were taken to stop progress sooner.
But, how can progress be made if failure is disallowed because of unknowingly giving people false hope?
But selling it to patients as an ALS therapy in the meantime outside of that trial, when it looked very dubious that it did anything-- that was a little questionable. The FDA overruling their own advisory committee to make this possible looks like a regulatory failure.
You saw the price? $158k per year list price, though it is implied people probably paid less.
You are overselling the effects of this drug harder than the manufacturer did.
That's why quacks are so infuriating other than money they take (even in social medical systems) time is lost which means disease progression. For many diseases there is now cure but there may drugs to slow it down. The drugs may take a long time to work so years spent on fake crap may mean it's too late for a person to go on a drug.